Biderra
Health and medical396512-2026

Greece – Renal support devices – ΠΡΟΜΗΘΕΙΑ ΑΝΑΛΩΣΙΜΟΥ ΥΛΙΚΟΥ ΜΟΝΑΔΑΣ ΤΕΧΝΗΤΟΥ ΝΕΦΡΟΥ

ΚΡΑΤΙΚΟ ΘΕΡΑΠΕΥΤΗΡΙΟ- ΓΕΝΙΚΟ ΝΟΣΟΚΟΜΕΙΟ- ΚΕΝΤΡΟ ΥΓΕΙΑΣ ΛΕΡΟΥ

Open official TED notice Similar notices

Buyer country

Greece

Publication date

Not specified

Biderra sector

Health and medical

Data source

TED open data

Decision signals

First-pass opportunity review

These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.

Timing signal
Deadline not indexed

Check the official notice

Indexed data completeness
100%

Based on seven decision fields

Official title coverage
7 languages

Preserved from source-supplied versions

Classification signal
33181000

Medical equipment, pharmaceuticals and personal care products

Official title versions

TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.

Spanish

Grecia – Dispositivos para hemodiálisis – ΠΡΟΜΗΘΕΙΑ ΑΝΑΛΩΣΙΜΟΥ ΥΛΙΚΟΥ ΜΟΝΑΔΑΣ ΤΕΧΝΗΤΟΥ ΝΕΦΡΟΥ

Dutch

Griekenland – Apparatuur voor nierdialyse – ΠΡΟΜΗΘΕΙΑ ΑΝΑΛΩΣΙΜΟΥ ΥΛΙΚΟΥ ΜΟΝΑΔΑΣ ΤΕΧΝΗΤΟΥ ΝΕΦΡΟΥ

Polish

Grecja – Urządzenia do terapii nerkowej – ΠΡΟΜΗΘΕΙΑ ΑΝΑΛΩΣΙΜΟΥ ΥΛΙΚΟΥ ΜΟΝΑΔΑΣ ΤΕΧΝΗΤΟΥ ΝΕΦΡΟΥ

French

Grèce – Appareils de suppléance rénale – ΠΡΟΜΗΘΕΙΑ ΑΝΑΛΩΣΙΜΟΥ ΥΛΙΚΟΥ ΜΟΝΑΔΑΣ ΤΕΧΝΗΤΟΥ ΝΕΦΡΟΥ

German

Griechenland – Ausrüstung für Nierendialyse – ΠΡΟΜΗΘΕΙΑ ΑΝΑΛΩΣΙΜΟΥ ΥΛΙΚΟΥ ΜΟΝΑΔΑΣ ΤΕΧΝΗΤΟΥ ΝΕΦΡΟΥ

Italian

Grecia – Apparecchi per emodialisi – ΠΡΟΜΗΘΕΙΑ ΑΝΑΛΩΣΙΜΟΥ ΥΛΙΚΟΥ ΜΟΝΑΔΑΣ ΤΕΧΝΗΤΟΥ ΝΕΦΡΟΥ

English

Greece – Renal support devices – ΠΡΟΜΗΘΕΙΑ ΑΝΑΛΩΣΙΜΟΥ ΥΛΙΚΟΥ ΜΟΝΑΔΑΣ ΤΕΧΝΗΤΟΥ ΝΕΦΡΟΥ

What Biderra adds

For notice 396512-2026, Biderra has normalized the contracting authority country as Greece, grouped CPV 33181000 under health and medical, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.